Chlorotoxin-modified macromolecular contrast agent for MRI tumor diagnosis

Biomaterials

Volumn 32, Issue 22, 2011, Pages 5177-5186

  Huang, Rongqin ^a,b   Han, Liang ^a,b   Li, Jianfeng ^a,b   Liu, Shuhuan ^a,b   Shao, Kun ^a,b   Kuang, Yuyang ^a,b   Hu, Xing ^a,b   Wang, Xuxia ^c   Lei, Hao ^c   Jiang, Chen ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Ministry of Education and PLA   (China)

^c Wuhan National Laboratory for Optoelectronics   (China)

Author keywords

Chlorotoxin; Contrast agent; DGLs; MRI; Targeted tumor diagnosis.

Indexed keywords

CHLOROTOXIN; CONTRAST AGENT; DGLS; MRI; TARGETED TUMOR DIAGNOSIS.;

AMINO ACIDS; BIOMATERIALS; CELL CULTURE; DENDRIMERS; DIAGNOSIS; GADOLINIUM; MACROMOLECULES; MAGNETIC RESONANCE IMAGING; RESONANCE;

TUMORS;

CHLOROTOXIN; DENDRIMER; GADOLINIUM PENTETATE; LIGAND; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PEPTIDE DERIVATIVE; POLYLYSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; CANCER CELL CULTURE; CONJUGATE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG SYNTHESIS; FLUORESCENCE MICROSCOPY; GLIOMA; HUMAN; IMAGE ENHANCEMENT; IN VIVO STUDY; LIVER TUMOR; MACROMOLECULE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

ANIMALS; CONTRAST MEDIA; DENDRIMERS; HEK293 CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MATERIALS TESTING; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; POLYLYSINE; RATS; SCORPION VENOMS;

MUS; MUS MUSCULUS;

EID: 79956128895     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.03.075     Document Type: Article

References (31)

1. Lebdusková P., Sour A., Helm L., Tóth E., Kotek J., Lukes I., et al. Phosphinic derivative of DTPA conjugated to a G5 PAMAM dendrimer: an 17O and 1H relaxation study of its Gd(III) complex. Dalton Trans 2006, 28(28):3399-3406.
2. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999, 99(9):2293-2352.
3. Nwe K., Xu H., Regino C.A., Bernardo M., Ileva L., Riffle L., et al. A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives. Bioconjug Chem 2009, 20(7):1412-1418.
4. Luo K., Liu G., Zhang X., She W., He B., Nie Y., et al. Functional L-lysine dendritic macromolecules as liver-imaging probes. Macromol Biosci 2009, 9(12):1227-1236.
5. Swanson S.D., Kukowska-Latallo J.F., Patri A.K., Chen C., Ge S., Cao Z., et al. Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement. Int J Nanomedicine 2008, 3(2):201-210.
6. Boswell C.A., Eck P.K., Regino C.A., Bernardo M., Wong K.J., Milenic D.E., et al. Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers. Mol Pharm 2008, 5(4):527-539.
7. Xu H., Regino C.A., Koyama Y., Hama Y., Gunn A.J., Bernardo M., et al. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjug Chem 2007, 18(5):1474-1482.
8. Svenson S. Dendrimers as versatile platform in drug delivery applications. Eur J Pharm Biopharm 2009, 71(3):445-462.
9. Chen W.T., Thirumalai D., Shih T.T., Chen R.C., Tu S.Y., Lin C.I., et al. Dynamic contrast-enhanced folate-receptor-targeted mr imaging using a Gd-loaded PEG-dendrimer-folate conjugate in a mouse xenograft tumor model. Mol Imaging Biol 2010, 12(2):145-154.
10. Cottet H., Martin M., Papillaud A., Souaïd E., Collet H., Commeyras A. Determination of dendrigraft poly-L-lysine diffusion coefficients by taylor dispersion analysis. Biomacromolecules 2007, 8(10):3235-3243.
11. Tsogas I., Theodossiou T., Sideratou Z., Paleos C.M., Collet H., Rossi J.C., et al. Interaction and transport of poly(L-lysine) dendrigrafts through liposomal and cellular membranes: the role of generation and surface functionalization. Biomacromolecules 2007, 8(10):3263-3270.
12. Johannessen C., Kapitán J., Collet H., Commeyras A., Hecht L., Barron L.D. Poly(L-proline) II helix propensities in poly(L-lysine) dendrigraft generations from vibrational Raman optical activity. Biomacromolecules 2009, 10(6):1662-1664.
13. Lyons S.A., O'Neal J., Sontheimer H. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia 2002, 39(2):162-173.
14. Veiseh M., Gabikian P., Bahrami S.B., Veiseh O., Zhang M., Hackman R.C., et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res 2007, 67(14):6882-6888.
15. Sun C., Veiseh O., Gunn J., Fang C., Hansen S., Lee D., et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 2008, 4(3):372-379.
16. Veiseh O., Gunn J.W., Kievit F.M., Sun C., Fang C., Lee J.S., et al. Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small 2009, 5(2):256-264.
17. Mamelak A.N., Jacoby D.B. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 2007, 4(2):175-186.
18. Huang R.Q., Qu Y.H., Ke W.L., Zhu J.H., Pei Y.Y., Jiang C. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J 2007, 21(4):1117-1125.
19. Huang R.Q., Liu S.H., Shao K., Han L., Ke W.L., Liu Y., et al. Evaluation and mechanism studies of PEGylated dendrigraft poly-L-lysines as novel gene delivery vectors. Nanotechnology 2010, 21(26):265101.
20. Qi R., Gao Y., Tang Y., He R.R., Liu T.L., He Y., et al. PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression. AAPS J 2009, 11(3):395-405.
21. Dufès C., Uchegbu I.F., Schätzlein A.G. Dendrimers in gene delivery. Adv Drug Deliv Rev 2005, 57(15):2177-2202.
22. Majoros I.J., Thomas T.P., Mehta C.B., Baker J.R. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J Med Chem 2005, 48(19):5892-5899.
23. Huang R.Q., Ke W.L., Liu Y., Jiang C., Pei Y.Y. The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain. Biomaterials 2008, 29(2):238-246.
24. Youk H.J., Lee E., Choi M.K., Lee Y.J., Chung J.H., Kim S.H., et al. Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol. J Control Release 2005, 107(1):43-52.
25. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2(3):161-174.
26. Veiseh O., Kievit F.M., Gunn J.W., Ratner B.D., Zhang M. A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells. Biomaterials 2009, 30(4):649-657.
27. Kievit F.M., Veiseh O., Fang C., Bhattarai N., Lee D., Ellenbogen R.D., et al. Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma. ACS Nano 2010, 4(8):4587-4594.
28. Wan J., Meng X., Liu E., Chen K. Incorporation of magnetite nanoparticle clusters in fluorescent silica nanoparticles for high-performance brain tumor delineation. Nanotechnology 2010, 21(23):235104.
29. Yu X.F., Sun Z., Li M., Xiang Y., Wang Q.Q., Tang F., et al. Neurotoxin-conjugated upconversion nanoprobes for direct visualization of tumors under near-infrared irradiation. Biomaterials 2010, 31(33):8724-8731.
30. Fox M.E., Szoka F.C., Fréchet J.M. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res 2009, 42(8):1141-1151.
31. Erdogan S., Torchilin V.P. Gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes. Methods Mol Biol 2010, 605:321-334.